Endocrinology

>

The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.

Latest News

The HCPFive: Top News for Healthcare Providers from the Week of 1/26
The HCPFive: Top News for Healthcare Providers from the Week of 1/26

February 1st 2025

Our top 5 headlines include approvals for a non-opioid pain reliever, the latest indication for semaglutide, positive phase 2 data in MASH, and more.

FDA black and white logo | Credit: US Food and Drug Administration
FDA Approves Semaglutide (Ozempic) for Type 2 Diabetes, Chronic Kidney Disease

January 28th 2025

Enobosarm Protects Lean Mass in Topline Phase 2b Trial Results | Image Credit: Weill Cornell Medicine
Enobosarm Protects Lean Mass in Topline Phase 2b Trial Results

January 27th 2025

Thyroid Cancer Diagnoses Rise in First Year of GLP-1 RA Use | Image Credit: University of Maryland
Thyroid Cancer Diagnoses Rise in First Year of GLP-1 RA Use

January 24th 2025

Patient Factors Influence Semaglutide Initiation After Obesity Diagnosis | Image Credit: Boston University
Patient Factors Influence Semaglutide Initiation After Obesity Diagnosis

January 21st 2025

Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP

Thumbnail logo for Diabetes Dialogue podcast
Latest CME Events & Activities
<1
...
147148149150151
© 2025 MJH Life Sciences

All rights reserved.